Qbrelis FDA Approval History
Last updated by Judith Stewart, BPharm on March 2, 2021.
FDA Approved: Yes (First approved July 29, 2016)
Brand name: Qbrelis
Generic name: lisinopril
Dosage form: Oral Solution
Company: Azurity Pharmaceuticals, Inc.
Treatment for: High Blood Pressure, Heart Failure, Heart Attack
Qbrelis (lisinopril) is an oral solution formulation of the approved angiotensin converting enzyme (ACE) inhibitor lisinopril indicated for the treatment of hypertension in adult patients and pediatric patients 6 years of age and older, adjunct therapy for heart failure, and treatment of acute myocardial infarction in adults.
Development timeline for Qbrelis
| Date | Article |
|---|---|
| Jul 29, 2016 | Approval FDA Approves Qbrelis (lisinopril) Oral Solution for Pediatric Patients 6 Years of Age and Older |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
